Ameriflex Group Inc. Decreases Stake in Intuitive Surgical, Inc. $ISRG

Ameriflex Group Inc. cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 66.4% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 286 shares of the medical equipment provider’s stock after selling 565 shares during the quarter. Ameriflex Group Inc.’s holdings in Intuitive Surgical were worth $153,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Chilton Capital Management LLC raised its position in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 43 shares during the last quarter. Elite Financial Inc. purchased a new position in Intuitive Surgical during the 1st quarter worth approximately $26,000. LFA Lugano Financial Advisors SA purchased a new position in Intuitive Surgical during the 1st quarter worth approximately $30,000. TD Capital Management LLC raised its position in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 45 shares during the last quarter. Finally, 1248 Management LLC purchased a new position in Intuitive Surgical during the 1st quarter worth approximately $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Up 2.1%

NASDAQ ISRG opened at $452.35 on Friday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The business’s fifty day simple moving average is $463.55 and its 200-day simple moving average is $500.06. The firm has a market cap of $162.16 billion, a PE ratio of 63.09, a P/E/G ratio of 4.74 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company’s quarterly revenue was up 21.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.78 EPS. Research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have issued reports on the stock. BTIG Research reissued a “buy” rating and set a $571.00 price target on shares of Intuitive Surgical in a research report on Wednesday. The Goldman Sachs Group cut their target price on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a report on Wednesday. UBS Group lifted their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a report on Wednesday, July 23rd. Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. Finally, Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Fourteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $594.19.

Insider Activity at Intuitive Surgical

In related news, Director Amy L. Ladd sold 335 shares of the business’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the sale, the director directly owned 739 shares in the company, valued at approximately $325,669.91. The trade was a 31.19% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 45,224 shares of company stock worth $21,716,492. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.